课题基金 / 基金详情

项目摘要

项目成果

Roger Keith Reeves的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
One of the greatest added values of the HU CFAR has been accelerated member access to new and emerging technologies. In the previous two competing submissions, these technologies have been largely provided through the Molecular Biology & Genomics Core and the Immunology Core. Services provided have focused largely on genomic and flow cytometic technologies, and have evolved over time, continuing to provide members with support that would be otherwise inaccessible to individual investigators. Based on our 2012 CFAR Strategic Review, the membership concluded that by integrating these cores and focusing on the intersection of advanced immunologic and genomic technologies and the increasing computational challenges associated with these, we could better leverage CFAR resources to serve members. These two cores were thus merged and redefined to form a single Advanced Technologies Core (ATC). The overall mission of the new Advanced Technologies Core is to provide access to advanced cytometric/genomic technologies and the computational methodologies that are an increasingly challenging barrier to individual investigators. At the current time, much of the identified need for members is in the capture of information regarding the phenotypic and functional state of individual cells, indexing these samples, and then capitalizing on this precious biomaterial to develop a comprehensive picture of the genomic landscape that exists in particular disease states. To ensure that all Harvard CFAR laboratories have access to this remarkable analytical power, this core will facilitate access to such technologies through the following aims: 1) Provide CFAR member access to state-of-the art technologies. 2) Providing user training in the above technologies, as well as computational assistance. 3) Building a virtual community using state of the art sharing and distribution tools.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Microbial and innate immune mechanisms of oral inflammation during SIV infection
  • 批准号:
    10408915
  • 项目类别:
  • 资助金额:
    $20.93万
  • 财政年份:
    2021
  • 负责人:
    Roger Keith Reeves
  • 依托单位:
NK cell mobilization as a pathogenic etiology of SARS-CoV-2 gastrointestinal disease
  • 批准号:
    10319735
  • 项目类别:
  • 资助金额:
    $40.25万
  • 财政年份:
    2021
  • 负责人:
    Roger Keith Reeves
  • 依托单位:
Mechanisms of Natural Killer Cell Clearance of SIV from Lymphoid Follicles
  • 批准号:
    10408913
  • 项目类别:
  • 资助金额:
    $69.76万
  • 财政年份:
    2021
  • 负责人:
    Roger Keith Reeves
  • 依托单位:
NK cell mobilization as a pathogenic etiology of SARS-CoV-2 gastrointestinal disease
  • 批准号:
    10458737
  • 项目类别:
  • 资助金额:
    $40.25万
  • 财政年份:
    2021
  • 负责人:
    Roger Keith Reeves
  • 依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
  • 批准号:
    2021JJ40433
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    孙磊
  • 依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
  • 批准号:
    32001603
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    段真珍
  • 依托单位:
AREA国际经济模型的移植.改进和应用
  • 批准号:
    18870435
  • 项目类别:
    面上项目
  • 资助金额:
    2.0万元
  • 批准年份:
    1988
  • 负责人:
    史树中
  • 依托单位: